Yazar "Ordu C." için listeleme
-
Adjuvant treatment modalities for gastric cancer
Gastric cancer is a leading cause of cancer-related death and thus represents a significant global health concern. Surgical resection remains the only effective curative treatment of gastric cancer. Less than 40% of cases ... -
Bilateral synchronous adrenal metastasis of invasive ductal carcinoma treated with multimodality therapy including adrenalectomy and oophorectomy
Eren O.O.; Ordu C.; Selcuk N.A.; Akosman C.; Ozturk M.A.; Ozkan F.; Oyan B. (SAGE Publications Ltd, 2016)A 38-year-old woman presented with a mass in the left breast. Biopsy of the lesion revealed invasive ductal carcinoma. Bilateral adrenal metastasis was detected in whole body positron emission tomography scanning. Needle ... -
Comparison of metabolic and anatomic response to chemotherapy based on PERCIST and RECIST in patients with advanced stage non-Small cell lung cancer
Ordu C.; Selcuk N.A.; Akosman C.; Eren O.O.; Altunok E.C.; Toklu T.; Oyan B. (Asian Pacific Organization for Cancer Prevention, 2015)Background: The aim of this study was to explore the prognostic role of metabolic response to chemotherapy, determined by FDG-PET, in patients with metastatic non-small-cell lung cancer (NSCLC). Materials and Methods: ... -
Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: Can we avoid radiotherapy in a subgroup of patients?
Adjuvant chemoradiotherapy (CRT) is the standard of care for gastric cancer patients in the USA. However, in countries where D2 lymph node dissection is performed, the effect of radiotherapy on locoregional recurrence is ... -
Erratum to Prolonged pleural catheters in the management of pleural effusions due to breast cancer [J Thorac Dis, 6, (2014) 8-74]
Demirhan O.; Ordu C.; Toker A. (Pioneer Bioscience Publishing, 2014)[No abstract available]